Topamax May Raise Risk of Birth Defects
Small Study Shows Increase in Birth Defects When Epilepsy/Migraine Drug Is Used During Pregnancy
The epilepsy and migraine prevention drug Topamax has been linked to an increased risk of birth defects in babies born to epilepsy patients who took it during pregnancy, a small study shows.
In a study published in the latest issue of the journal Neurology, taking Topamax (topiramate) during pregnancy was associated with a birth defect risk within the range of risk seen in other anti-epileptic drugs, researchers reported.
To read the entire article click HERE.
The epilepsy and migraine prevention drug Topamax has been linked to an increased risk of birth defects in babies born to epilepsy patients who took it during pregnancy, a small study shows.
In a study published in the latest issue of the journal Neurology, taking Topamax (topiramate) during pregnancy was associated with a birth defect risk within the range of risk seen in other anti-epileptic drugs, researchers reported.
To read the entire article click HERE.
Posts
0 comments:
Post a Comment